Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Malaysia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20072
20083
20103
20113
20124
20133
20141
20161
20171
20181
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated6
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Alkermes, Inc.3
Janssen Research & Development, LLC3
Sumitomo Pharma America, Inc.3
Sumitomo Pharma Co., Ltd.3
AstraZeneca2
Boehringer Ingelheim2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
AbbVie1
H. Lundbeck A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia29
Autistic Disorder1
Bipolar Disorder1
Disease1
Mania1
Schizophrenia, Treatment-Resistant1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.